Assignee
NEUROLIXIS
FR·3 granted patents·0 citations·filing 2017–2022
Top patents by PatentIndex Score
3 records- 0156US11974992B2Use of serotonin 5-HT1A receptor agonists to treat diseases associated with sudden unexpected death in epilepsyNEUROLIXIS·Filed 2022·Granted May 7, 2024·0 cites·3 claims
- 0247US10562853B2Compounds for treating disorders sensitive to serotoninergic regulation controlled by the 5-HT1A receptorsNEUROLIXIS·Filed 2017·Granted Feb 18, 2020·0 cites·29 claims
- 0340US11191758B2Use of selective serotonin 5-HT1A receptor agonists for treating side-effects of VMAT inhibitorsNEUROLIXIS·Filed 2018·Granted Dec 7, 2021·0 cites·6 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →